{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-26-000035","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2026-07-29T20:07:39+00:00","discovered_at":"2026-07-29T20:09:00.303891+00:00","generated_at":"2026-07-29T20:09:26.710321+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pulmonx Q2 revenue $22.8M (-5% YoY); net loss narrows to $10.1M","bullets":["Revenue $22.8M, down 5% YoY; U.S. $14.2M (-4%), international $8.6M (-6%; ex-China +12%).","Record gross margin 78% (vs 72% YoY); operating expenses down 16% to $26.8M.","Net loss $10.1M ($0.24/share) vs $15.2M loss; adjusted EBITDA loss $5.1M, down 39%.","Cash $55.8M; FY2026 guidance: revenue $90-92M, gross margin ~76%, opex $109-111M.","Management cites cost realignment and expects return to year-over-year revenue growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-26-000035","json":"https://secwatch.observer/filing/0001127537-26-000035.json","markdown":"https://secwatch.observer/filing/0001127537-26-000035.md","text":"https://secwatch.observer/filing/0001127537-26-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753726000035/0001127537-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753726000035/lung-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T20:09:26.710321+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}